Dr. George M. Rajacich, MD

Dr. Rajacich practices at Mazzocco Ambulatory Surgical Center (Vanowen St) in Vannuys, California.

Dr. Rajacich's NPI, 1962407593, was assigned on June 20, 2005. Dr. Rajacich graduated from David Geffen School of Medicine at UCLA in 1979. Dr. Rajacich holds California license G44103.

Dr. Rajacich's primary practice is Mazzocco Ambulatory Surgical Center (Vanowen St), at 15243 Vanowen St, Vannuys, CA 91405. The practice phone is (818) 787-2020.

Dr. Rajacich's primary practice is Mazzocco Ambulatory Surgical Center (Vanowen St) in Vannuys, California. Dmand AI also links Dr. Rajacich to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajacich practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rajacich's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rajacich is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Rajacich is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Rajacich treats.

CMS data shows 5,514 Medicare services from Dr. Rajacich across 17 procedure codes in 2024, for 1,429 Medicare patients. Medicare paid $496,907 for them.

CMS counts 1,429 Medicare patients who saw Dr. Rajacich in 2024. The largest group is 75 to 84, with 582 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rajacich's median patient age at 73, with 60% women.

In 2024, Dr. Rajacich wrote 1,952 Medicare Part D claims for 550 patients. 57% of them were for generic drugs. CMS names the drug for 1,848 of them, across 25 drugs with 11 or more claims each, at $193,164 in total drug cost. In 2023, CMS named 2,367 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rajacich for performance year 2024, reported individually. Dr. Rajacich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 194 procedures of cataract surgery by Dr. Rajacich, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Rajacich. Dr. Rajacich's most frequent co-author is Michael S. Berlin, MD.

CMS Open Payments shows 188 general payments to Dr. Rajacich from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Alcon Laboratories Inc paid the most, $1,774.

Dmand AI lists 3 awards for Dr. Rajacich.

Dr. Rajacich graduated from David Geffen School of Medicine at UCLA in 1979. Dr. Rajacich is a member of AAO and ACS.

Dr. Rajacich is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.